Please login to the form below

Not currently logged in
Email:
Password:

asthma

This page shows the latest asthma news and features for those working in and with pharma, biotech and healthcare.

Detailed results for Regeneron's antibody cocktail continue to show benefit in high-risk COVID-19 outpatients

Detailed results for Regeneron's antibody cocktail continue to show benefit in high-risk COVID-19 outpatients

Despite increasing vaccination rates, many continue to be diagnosed with COVID-19 who could benefit from REGEN-COV due to underlying conditions like asthma or COPD that put them at higher

Latest news

More from news
Approximately 66 fully matching, plus 493 partially matching documents found.

Latest Intelligence

  • Mapping at launch: it’s time to update the satnav Mapping at launch: it’s time to update the satnav

    COPD. It has recently been approved by the FDA for asthma too, but our analysis focuses on UK performance.

  • On our best behaviour On our best behaviour

    Historically, asthma patients were responsible for recording their own symptoms and exacerbations, which can be difficult to remember over long periods. ... The Propeller platform has been shown to increase medication adherence by up to 58%, increase

  • Exploring the potential of eosinophils Exploring the potential of eosinophils

    Working as a clinician at this time meant he was caring for patients with allergies and asthma, in particular severe asthma. ... Sputum provides a sample of the central airways which only makes up 10% of the airways, but asthma affects the whole of the

  • Could formulary intelligence be your brand differentiator?

    Sirdupla – a branded generic to Seretide (asthma), offering good cost savings for medicines management.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    The software helps differentiate patients from those suffering with similar symptoms that are actually a result of asthma and chronic obstructive pulmonary disease (COPD), and therefore diagnose CTEPH more reliably and

More from intelligence
Approximately 3 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Article

    Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma. ... Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and some key findings from recent studies

  • Addressing Climate Impact: The Healthcare Paradox Addressing Climate Impact: The Healthcare Paradox

    Boehringer Ingelheim recently introduced the first reusable, propellant-free inhaler for patients with asthma and COPD, supporting objectives of carbon and plastic waste reduction.

  • How will the Tories’ historic win shape the NHS?

    conditions remotely, has huge potential for the NHS.  For example, with long term conditions such as asthma and diabetes, remote monitoring enables better self-management, which in turn, should lead to

  • Digital therapeutics and their impact on society

    This is in part due to the explosive, bordering on unmanageable, increase in chronic diseases, such as cardiovascular disease, diabetes, Alzheimer’s disease, obesity and asthma.

  • RWE Blog 1: Real-world challenges and real-world data

    In  a review of 870 out-patients with asthma and/or Chronic Obstructive Pulmonary Disease (COPD), only one in 20 asthma patients and one in six COPD patients met the typical

More from PMHub
Approximately 3 fully matching, plus 21 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...